We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK’s Competition Authority Fines Pfizer, Flynn Pharma for Price Hikes of Epilepsy Drug
UK’s Competition Authority Fines Pfizer, Flynn Pharma for Price Hikes of Epilepsy Drug
UK’s antitrust regulator has charged Pfizer and Flynn Pharma a fine totaling more than $100 million for hiking the prices of their phenytoin sodium capsules for epilepsy.